Nitric oxide synthase expression of oligodendrogliomas

Area of Science:

• Neuroscience
• Oncology
• Biochemistry

Background:

• Nitric oxide (NO) plays crucial roles in the central nervous system, including neurotransmission and vasodilation.
• NO synthesis is regulated by three isoforms of NO synthase (NOS): neuronal NOS (nNOS), inducible NOS (iNOS), and endothelial NOS (eNOS).
• Altered NOS expression is implicated in the pathophysiology of high-grade astrocytic tumors (WHO grades III and IV).

Purpose of the Study:

• To investigate the expression of all three NOS isoforms in oligodendrogliomas, a distinct group of primary gliomas.
• To correlate NOS expression patterns with tumor grade (WHO grade II and III) and compare them with astrocytoma findings.
• To explore the potential role of NO and its synthases in oligodendroglioma biology and progression.

Main Methods:

• Immunohistochemical analysis of NOS isoform expression (nNOS, iNOS, eNOS) in 35 WHO grade II oligodendrogliomas and 7 WHO grade III anaplastic oligodendrogliomas.
• Utilized formalin-fixed, paraffin-embedded tissue samples for examination.
• Correlated findings with tumor grade and astrocytoma expression patterns.

Main Results:

• Tumor cells showed minimal nNOS and sparse eNOS expression.
• Vascular endothelial cells in both tumor and surrounding tissues exhibited strong eNOS expression, suggesting NO's role in regulating blood flow and angiogenesis in these tumors.
• Significantly, inducible NOS (iNOS) was expressed in oligodendroglial tumor cells in 54% of low-grade and 29% of anaplastic tumors, a pattern distinct from astroglial tumors.

Conclusions:

• Endothelial NOS (eNOS) in oligodendroglioma vasculature likely influences tumor vascularity and angiogenesis.
• The observed iNOS expression in oligodendroglial tumor cells diverges from astroglial tumors and may suggest an anti-tumor function.
• This iNOS activity could potentially contribute to a slower progression from low-grade to anaplastic oligodendrogliomas.